FCFS

162.15

+1.57%↑

RPT.US

2.44

+1.67%↑

FCFS

162.15

+1.57%↑

RPT.US

2.44

+1.67%↑

FCFS

162.15

+1.57%↑

RPT.US

2.44

+1.67%↑

FCFS

162.15

+1.57%↑

RPT.US

2.44

+1.67%↑

FCFS

162.15

+1.57%↑

RPT.US

2.44

+1.67%↑

Search

Equasens

Fermé

36.95 1.37

Résumé

Variation du prix de l'action

24h

Actuel

Min

35.6

Max

37.8

Chiffres clés

By Trading Economics

Revenu

-1.8M

17M

Ventes

7.2M

116M

P/E

Moyenne du Secteur

15.69

Rendement du dividende

3.29

Marge bénéficiaire

14.879

Employés

1,400

EBITDA

178M

116M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.29%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-44M

564M

Ouverture précédente

35.58

Clôture précédente

36.95

Equasens Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

4 nov. 2025, 23:57 UTC

Résultats

Naver's Third-Quarter Earnings Rose on AI Push

4 nov. 2025, 23:10 UTC

Acquisitions, Fusions, Rachats

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4 nov. 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 nov. 2025, 23:48 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4 nov. 2025, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4 nov. 2025, 23:30 UTC

Résultats

Itau Unibanco 3Q Net BRL33.7B >ITUB

4 nov. 2025, 23:25 UTC

Résultats

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4 nov. 2025, 23:25 UTC

Résultats

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4 nov. 2025, 23:24 UTC

Résultats

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4 nov. 2025, 23:23 UTC

Résultats

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4 nov. 2025, 23:06 UTC

Résultats

Review & Preview: Tech Check -- Barrons.com

4 nov. 2025, 22:52 UTC

Résultats

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4 nov. 2025, 22:33 UTC

Résultats

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4 nov. 2025, 22:29 UTC

Résultats

Ashland 4Q Adj EPS $1.08 >ASH

4 nov. 2025, 22:29 UTC

Résultats

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4 nov. 2025, 22:28 UTC

Résultats

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4 nov. 2025, 22:27 UTC

Résultats

Ashland 4Q Cont Ops EPS 73c >ASH

4 nov. 2025, 22:27 UTC

Résultats

Ashland 4Q EPS 71c >ASH

4 nov. 2025, 22:27 UTC

Résultats

Ashland 4Q Sales $478M >ASH

4 nov. 2025, 22:23 UTC

Résultats

Ovintiv 3Q EPS 57c >OVV

4 nov. 2025, 22:19 UTC

Market Talk

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4 nov. 2025, 22:16 UTC

Résultats

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4 nov. 2025, 22:14 UTC

Acquisitions, Fusions, Rachats

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4 nov. 2025, 22:13 UTC

Acquisitions, Fusions, Rachats

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4 nov. 2025, 22:13 UTC

Acquisitions, Fusions, Rachats

Consortium: Able to Finance a Deal With Available Liquidity

4 nov. 2025, 22:12 UTC

Acquisitions, Fusions, Rachats

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4 nov. 2025, 22:11 UTC

Résultats

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4 nov. 2025, 22:11 UTC

Acquisitions, Fusions, Rachats

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4 nov. 2025, 22:10 UTC

Acquisitions, Fusions, Rachats

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 nov. 2025, 22:07 UTC

Résultats

Kinross Gold Raises Dividend to $0.035 >K.T

Comparaison

Variation de prix

Equasens prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Equasens

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat